We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Meridian Bioscience Inc | NASDAQ:VIVO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 33.97 | 33.97 | 34.00 | 0 | 01:00:00 |
Date of Report (Date of earliest event reported):
|
October 18, 2016
|
MERIDIAN BIOSCIENCE, INC.
|
(Exact name of registrant as specified in its charter)
|
Ohio
|
0-14902
|
31-0888197
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No. )
|
3471 River Hills Drive, Cincinnati, Ohio
|
45244
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant's telephone number, including area code
|
(513) 271-3700
|
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
99.1 | Press Release of the Company dated October 18, 2016 |
Date: October 20, 2016
|
MERIDIAN BIOSCIENCE, INC.
By:
/s/ Melissa A. Lueke
Melissa A. Lueke
Executive Vice President and
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
1 Year Meridian Bioscience Chart |
1 Month Meridian Bioscience Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions